Literature DB >> 33685902

Missense Mutations in the CrrB Protein Mediate Odilorhabdin Derivative Resistance in Klebsiella pneumoniae.

Lucile Pantel1, Paulo Juarez2, Marine Serri1, Lilia Boucinha3, Emilie Lessoud3, Anne Lanois4, Alain Givaudan4, Emilie Racine1, Maxime Gualtieri5.   

Abstract

NOSO-502 is a preclinical antibiotic candidate of the Odilorhabdin class. This compound exhibits activity against Enterobacteriaceae pathogens, including carbapenemase-producing bacteria and most of the Colistin (CST)-resistant strains. Among a collection of CST-resistant Klebsiella pneumoniae strains harboring mutations on genes pmrAB, mgrB, phoPQ, and crrB, only those bearing mutations in gene crrB were found to be resistant to NOSO-502.CrrB is a histidine kinase which acts with the response regulator CrrA to modulate the PmrAB system, which finally induces the restructuring of the lipopolysaccharide present on the outer membrane and thus leading to CST resistance. Moreover, crrB mutations also enhance the transcription of neighboring genes such as H239_3063, an ABC transporter transmembrane region; H239_3064, a putative efflux pump also known as KexD; and H239_3065, a N-acetyltransferase.To elucidate the mechanism of resistance to NOSO-502 induced by CrrB missense mutations in K. pneumoniae, mutants of NCTC 13442 and ATCC BAA-2146 strains resistant to NOSO-502 and CST with single amino acid substitutions in CrrB (S8N, F33Y, Y34N, W140R, N141I, P151A, P151L, P151S, P151T, F303Y) were selected. Full susceptibility to NOSO-502 was restored in crrA or crrB deleted K. pneumoniae NCTC 13442 CrrB(P151L) mutants, confirming the role of CrrAB in controlling this resistance pathway. Deletion of kexD (but no other neighboring genes) in the same mutant also restored NOSO-502-susceptibility. Upregulation of the kexD gene expression was observed for all CrrB mutants. Finally, plasmid expression of kexD in a K. pneumoniae strain missing the locus crrABC and kexD significantly increased resistance to NOSO-502.
Copyright © 2021 American Society for Microbiology.

Entities:  

Year:  2021        PMID: 33685902      PMCID: PMC8092918          DOI: 10.1128/AAC.00139-21

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  34 in total

Review 1.  Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria.

Authors:  Laura J V Piddock
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

Review 2.  Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections.

Authors:  Jian Li; Roger L Nation; John D Turnidge; Robert W Milne; Kingsley Coulthard; Craig R Rayner; David L Paterson
Journal:  Lancet Infect Dis       Date:  2006-09       Impact factor: 25.071

Review 3.  The global epidemiology of carbapenemase-producing Enterobacteriaceae.

Authors:  David van Duin; Yohei Doi
Journal:  Virulence       Date:  2016-08-11       Impact factor: 5.882

4.  Molecular epidemiology of KPC-producing Klebsiella pneumoniae from invasive infections in Italy: increasing diversity with predominance of the ST512 clade II sublineage.

Authors:  Viola Conte; Monica Monaco; Tommaso Giani; Fortunato D'Ancona; Maria Luisa Moro; Fabio Arena; Marco Maria D'Andrea; Gian Maria Rossolini; Annalisa Pantosti
Journal:  J Antimicrob Chemother       Date:  2016-09-01       Impact factor: 5.790

5.  In Vivo Pharmacodynamic Characterization of a Novel Odilorhabdin Antibiotic, NOSO-502, against Escherichia coli and Klebsiella pneumoniae in a Murine Thigh Infection Model.

Authors:  Miao Zhao; Alexander J Lepak; Karen Marchillo; Jamie VanHecker; David R Andes
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

6.  Broad-host-range expression vectors that carry the L-arabinose-inducible Escherichia coli araBAD promoter and the araC regulator.

Authors:  J R Newman; C Fuqua
Journal:  Gene       Date:  1999-02-18       Impact factor: 3.688

7.  Amino Acid Substitutions of CrrB Responsible for Resistance to Colistin through CrrC in Klebsiella pneumoniae.

Authors:  Yi-Hsiang Cheng; Tzu-Lung Lin; Yi-Tsung Lin; Jin-Town Wang
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

8.  In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator.

Authors:  Antonio Cannatelli; Marco Maria D'Andrea; Tommaso Giani; Vincenzo Di Pilato; Fabio Arena; Simone Ambretti; Paolo Gaibani; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2013-08-26       Impact factor: 5.191

9.  Prevalence and molecular determinants of colistin resistance among commensal Enterobacteriaceae isolated from poultry in northwest of Iran.

Authors:  Zeinab Pishnian; Mehri Haeili; Adel Feizi
Journal:  Gut Pathog       Date:  2019-01-31       Impact factor: 4.181

10.  Morphological, genomic and transcriptomic responses of Klebsiella pneumoniae to the last-line antibiotic colistin.

Authors:  Amy K Cain; Christine J Boinett; Lars Barquist; Janina Dordel; Maria Fookes; Matthew Mayho; Matthew J Ellington; David Goulding; Derek Pickard; Ryan R Wick; Kathryn E Holt; Julian Parkhill; Nicholas R Thomson
Journal:  Sci Rep       Date:  2018-06-29       Impact factor: 4.379

View more
  1 in total

1.  The Odilorhabdin Antibiotic Biosynthetic Cluster and Acetyltransferase Self-Resistance Locus Are Niche and Species Specific.

Authors:  Anne Lanois-Nouri; Lucile Pantel; Jun Fu; Jessica Houard; Jean-Claude Ogier; Yury S Polikanov; Emilie Racine; Hailong Wang; Sophie Gaudriault; Alain Givaudan; Maxime Gualtieri
Journal:  mBio       Date:  2022-01-11       Impact factor: 7.867

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.